Clinical trial
Revealing Mechanisms and Investigating Efficacy of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis - a Multicentric Randomized Controlled Group Sequential Trial
NCT03266302 is registered in ClinicalTrials.gov with Jena University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Revealing Mechanisms and Investigating Efficacy of Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis - a Multicentric Randomized Controlled Group Sequential Trial
- Lead sponsor
- Jena University Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 17, 2018
- Completion date
- December 31, 2020
- Enrollment
- 288 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
infective endocarditis